TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Pharmor AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,730
|
2,819
|
2,727 |
| Financial expenses |
321
|
413
|
571 |
| Earnings before taxes |
1,626
|
874
|
1,068 |
| EBITDA |
1,662
|
1,230
|
1,288 |
| Total assets |
5,859
|
4,314
|
3,699 |
| Current assets |
1,487
|
1,795
|
1,550 |
| Current liabilities |
1,028
|
865
|
637 |
| Equity capital |
4,397
|
3,113
|
2,764 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
75.0%
|
72.2%
|
74.7% |
| Turnover per employee |
3,730
|
2,819
|
2,727 |
| Profit as a percentage of turnover |
43.6%
|
31.0%
|
39.2% |
| Return on assets (ROA) |
33.2%
|
29.8%
|
44.3% |
| Current ratio |
144.6%
|
207.5%
|
243.3% |
| Return on equity (ROE) |
37.0%
|
28.1%
|
38.6% |
| Change turnover |
711
|
174
|
462 |
| Change turnover % |
24%
|
7%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.